neurosurgeryНейрохирургияRussian journal of neurosurgery1683-32952587-7569Издательский дом "МедИНК"neurosurgery-592Research ArticleОБЗОРЫ ЛИТЕРАТУРЫLITERATURE REVIEWПервичная лимфома центральной нервной системы: клиника , диагностика , современные подходы к лечениюБублиевскийД.В.ЕвзиковГ.Ю.Клиника нервных болезней ПМГМУ им. И.М. СеченоваRussian Federation2012310320121217481Copyright © Бублиевский Д., Евзиков Г., 20182018Бублиевский Д., Евзиков Г.Бублиевский Д., Евзиков Г.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.therjn.com/jour/article/view/592

В связи с ростом числа выявляемости первичной лимфомы центральной нервной системы (ПЛ ЦНС) у людей среднего и пожилого возраста в настоящее время достаточно остро стоит проблема своевременной диагностики и адекватного лечения данного заболевания. Настоящая статья представляет собой сжатый обзор проблемы диагностики и сравнительной оценки эффективности методов лечения ПЛЦНС. Представлены основные гистологические формы лимфомы, локализация опухолевого поражения и нейровизуализационные характеристики, особенности применения хирургии, лучевой и химиотерапии.

 

 

 

 

Nowadays the problem of on-time diagnosis and adequate treatment of primary central nervous system lymphoma is one of the top medical questions due to constantly increasing cases of this disease among people of middle and elderly age. This article presents the brief review of diagnosis problems and comparative estimation of efficacy of current methods for PL CNS treatment. The main histological types of lymphoma, tumor localizations, neurovisualization features as well as aspects of surgical, radiation and chemotherapy treatment modalities are enlighted in this written work.

В-клеточная лимфомаВААРТсолитарныймножественныйбиопсияметотрексаттемозоламидполихимиотерапиягематоэнцефалический барьер.cell lymphomaHAARTsolitarymultiplebiopsymethotrexatetemozolomoidepolychemotherapyblood-brain barrierReferencesБогданов А.Н., Максимов А.Г., Саржевский В.О., Аносов Н.А. Особые формы неходжкинских лимфом. Практическая онкология Т. 5, № 3. 2004. c. 216—222. Военно-медицинская академия, Санкт-Петербург.Богданов А.Н., Максимов А.Г., Саржевский В.О., Аносов Н.А. Особые формы неходжкинских лимфом. Практическая онкология Т. 5, № 3. 2004. c. 216—222. Военно-медицинская академия, Санкт-Петербург.Abrey L.E., DeAngelis L.M., Yahalom J. Long-term survival in primary CNS lymphoma // J Clin Oncol. 1998. Vol. 16. P. 859—863.Abrey L.E., DeAngelis L.M., Yahalom J. Long-term survival in primary CNS lymphoma // J Clin Oncol. 1998. Vol. 16. P. 859—863.Abrey L., Paulus W., Jellinger K., Morgello S., Deckert-Schluter M. Malignant lymphomas // World Health Organization Classification of Tumour Pathology and Genetics of Tumours of the Nervous System. Lyon: IARC Press, 2000. P. 198—203.Abrey L., Paulus W., Jellinger K., Morgello S., Deckert-Schluter M. Malignant lymphomas // World Health Organization Classification of Tumour Pathology and Genetics of Tumours of the Nervous System. Lyon: IARC Press, 2000. P. 198—203.Abrey L.E., Thiessen B., DeAngelis L.M. Treatment related neurotoxicity in primary CNS lymphoma. Society for Neuro-Oncology Annual Meeting. 1997. [abstract].Abrey L.E., Thiessen B., DeAngelis L.M. Treatment related neurotoxicity in primary CNS lymphoma. Society for Neuro-Oncology Annual Meeting. 1997. [abstract].Abrey L.E., Yahalom J, DeAngelis L.M. Treatment for primary CNS lymphoma: The next step // J Clin Oncol. 2000. Vol. 18. P. 3144—3150.Abrey L.E., Yahalom J, DeAngelis L.M. Treatment for primary CNS lymphoma: The next step // J Clin Oncol. 2000. Vol. 18. P. 3144—3150.Bailey P. Intracranial sarcomatous tumors of leptomeningeal origin // Arch Surg. 1929. Vol. 18. P. 1359—1402.Bailey P. Intracranial sarcomatous tumors of leptomeningeal origin // Arch Surg. 1929. Vol. 18. P. 1359—1402.Balmaceda C., Gaynor J.J., Sun M., Gluck J.T., DeAngelis L.M. Leptomeningeal tumor in primary central nervous system lymphoma: recognition, significance, and implications // Ann Neurol. 1995. Vol. 38. P. 202—209.Balmaceda C., Gaynor J.J., Sun M., Gluck J.T., DeAngelis L.M. Leptomeningeal tumor in primary central nervous system lymphoma: recognition, significance, and implications // Ann Neurol. 1995. Vol. 38. P. 202—209.Bataille B., Delwail V., Menet E., Vandermarcq P., Ingrand P., Wager M., et al. Primary intracerebral malignant lymphoma: report of 248 cases // J Neurosurg. 2000. Vol. 92. P. 261—266.Bataille B., Delwail V., Menet E., Vandermarcq P., Ingrand P., Wager M., et al. Primary intracerebral malignant lymphoma: report of 248 cases // J Neurosurg. 2000. Vol. 92. P. 261—266.Batchelor T., Carson K., O’Neill A., Grossman S.A., Alavi J., New P. et al. Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96—07 // J Clin Oncol. 2003. Vol. 21. P: 1044—1049.Batchelor T., Carson K., O’Neill A., Grossman S.A., Alavi J., New P. et al. Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96—07 // J Clin Oncol. 2003. Vol. 21. P: 1044—1049.Brink N.S., Sharvell Y., Howard M.R., Fox J.D., Harrison M.J., and Miller R.F. Detection of Epstein-Barr virus and Kaposi’s sarcoma-associated herpesvirus: DNA in CSF from persons infected with HIV who had neurological disease // J Neurol Neurosurg Psychiatry. 1998. Vol. 65. P. 191—195.Brink N.S., Sharvell Y., Howard M.R., Fox J.D., Harrison M.J., and Miller R.F. Detection of Epstein-Barr virus and Kaposi’s sarcoma-associated herpesvirus: DNA in CSF from persons infected with HIV who had neurological disease // J Neurol Neurosurg Psychiatry. 1998. Vol. 65. P. 191—195.Buggage R.R., Chan C.C., Nussenblatt R.B. Ocular manifestations of central nervous system lymphoma // Curr Opin Oncol. 2001. Vol. 13. P. 137—142.Buggage R.R., Chan C.C., Nussenblatt R.B. Ocular manifestations of central nervous system lymphoma // Curr Opin Oncol. 2001. Vol. 13. P. 137—142.Buhring U., Herrlinger U. MRI features of primary central system lymphoma in presentation // Neurology. 2001. Vol. 57, № 3. P. 393—396.Buhring U., Herrlinger U. MRI features of primary central system lymphoma in presentation // Neurology. 2001. Vol. 57, № 3. P. 393—396.Carbone Р.Р., Kaplan H.S., Broren V. et al. Report of the Committee on Hodgkin`s disease staging classification // Cancer research. 1971. Vol. 31. P. 1860—1861.Carbone Р.Р., Kaplan H.S., Broren V. et al. Report of the Committee on Hodgkin`s disease staging classification // Cancer research. 1971. Vol. 31. P. 1860—1861.CBTRUS: Primary Brain Tumors in the United States, 1998—2002. Statistical Report. Chicago: Central Brain Tumor Registry of the United States, 2005.CBTRUS: Primary Brain Tumors in the United States, 1998—2002. Statistical Report. Chicago: Central Brain Tumor Registry of the United States, 2005.Cheng T. et al. High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma // Bone Marrow Transplant. 2003. Vol. 31. P. 679—685.Cheng T. et al. High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma // Bone Marrow Transplant. 2003. Vol. 31. P. 679—685.Chow K.U., Mitrou P.S., Geduldig K., Helm E.B., Hoelzer D., Brodt H.R. Changing incidence and survival in patients with AID Srelated non-Hodgkin’s lymphomas in the era of highly active antiretroviral therapy (HAART) // Leuk Lymphoma. 2001. Vol. 41. P. 105—116.Chow K.U., Mitrou P.S., Geduldig K., Helm E.B., Hoelzer D., Brodt H.R. Changing incidence and survival in patients with AID Srelated non-Hodgkin’s lymphomas in the era of highly active antiretroviral therapy (HAART) // Leuk Lymphoma. 2001. Vol. 41. P. 105—116.Cote T.R., Manns A., Hardy C.R., Yellin F.J., Hartge P. Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome // J Natl Cancer Inst. 1996. Vol. 88. P. 675—679.Cote T.R., Manns A., Hardy C.R., Yellin F.J., Hartge P. Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome // J Natl Cancer Inst. 1996. Vol. 88. P. 675—679.DeAngelis L.M. Primary central nervous system lymphomas // Curr Treat Options Oncol. 2001. Vol. 2. P. 309—318.DeAngelis L.M. Primary central nervous system lymphomas // Curr Treat Options Oncol. 2001. Vol. 2. P. 309—318.DeAngelis L.M., Seiferheld W., Schold S.C., Fisher B., Schultz C.J. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93—100 // J Clin Oncol. 2002. Vol. 20. P. 4643—4648.DeAngelis L.M., Seiferheld W., Schold S.C., Fisher B., Schultz C.J. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93—100 // J Clin Oncol. 2002. Vol. 20. P. 4643—4648.DeAngelis L.M., Wong E., Rosenblum M., Furneaux H. Epstein Barr virus in AIDS and non AIDS primary central nervous system lymphoma // Cancer. 1992. Vol. 70. Р. 1607.DeAngelis L.M., Wong E., Rosenblum M., Furneaux H. Epstein Barr virus in AIDS and non AIDS primary central nervous system lymphoma // Cancer. 1992. Vol. 70. Р. 1607.DeAngelis L.M., Yahalom J., Heinemann M.H., Cirrincione C., Thaler H.T., Krol G. Primary CNS lymphoma: combined treat-ment with chemotherapy and radiotherapy // Neurology. 1990. Vol. 40. P. 80—86.DeAngelis L.M., Yahalom J., Heinemann M.H., Cirrincione C., Thaler H.T., Krol G. Primary CNS lymphoma: combined treat-ment with chemotherapy and radiotherapy // Neurology. 1990. Vol. 40. P. 80—86.Dina T.S. Primary central nervous system lymphoma versus toxoplasmosis in AIDS // Radiology. 1991. Vol. 179. P. 823—828.Dina T.S. Primary central nervous system lymphoma versus toxoplasmosis in AIDS // Radiology. 1991. Vol. 179. P. 823—828.Eloraby A., Zaki I. Primary central system lymphoma: incorporating MRI in the planning of treatment strategies // J Egypt Nat Canc Inst. 2001. Vol. 13, № 3. P. 237— 244.Eloraby A., Zaki I. Primary central system lymphoma: incorporating MRI in the planning of treatment strategies // J Egypt Nat Canc Inst. 2001. Vol. 13, № 3. P. 237— 244.Faro A., Kurland G. et al. Interferon-alpha affects the immune response in post-transplant lymphoproliferative disorder. Am J Respir Crit Care Med. 1996. Vol. 153. P. 1442— 1447.Faro A., Kurland G. et al. Interferon-alpha affects the immune response in post-transplant lymphoproliferative disorder. Am J Respir Crit Care Med. 1996. Vol. 153. P. 1442— 1447.Fine H.A., Mayer R.J. Primary central nervous lymphoma // Ann Intern Med. 1993. Vol. 119. P. 1093—1104.Fine H.A., Mayer R.J. Primary central nervous lymphoma // Ann Intern Med. 1993. Vol. 119. P. 1093—1104.Frick J.C., Hansen R.M., Anderson T. et al. Successful highdose intravenous cytarabine treatment of parenchymal brain involvement from malignant lymphoma // Arch Intern Med. 1986. Vol. 146. P. 791—792.Frick J.C., Hansen R.M., Anderson T. et al. Successful highdose intravenous cytarabine treatment of parenchymal brain involvement from malignant lymphoma // Arch Intern Med. 1986. Vol. 146. P. 791—792.Gavrilovic I. et al. Long-term follow-up of patients with primary central nervous system lymphoma treated with a high-dose methotrexate regimen with or without whole brain radiotherapy // Neuro-oncol. 2005. Vol. 7. P. 349.Gavrilovic I. et al. Long-term follow-up of patients with primary central nervous system lymphoma treated with a high-dose methotrexate regimen with or without whole brain radiotherapy // Neuro-oncol. 2005. Vol. 7. P. 349.Glass J., Gruber M.L., Cher L. et al. Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: Long-term outcome // J Neurosurg. 1994. Vol. 81. P. 188—195.Glass J., Gruber M.L., Cher L. et al. Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: Long-term outcome // J Neurosurg. 1994. Vol. 81. P. 188—195.Hartge P., Devessa S.S., Faunmeni J.F.Jr. Hodgkin’s and non-Hodgkin’s lymphoma // Cancer Surv. 1994. Vol. 20. P. 423.Hartge P., Devessa S.S., Faunmeni J.F.Jr. Hodgkin’s and non-Hodgkin’s lymphoma // Cancer Surv. 1994. Vol. 20. P. 423.Herrlinger U., Kuker W., Uhl M., Blaicher H.P., Karnath H.O., Kanz L. et al. NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final report // Ann Neurol. 2005. Vol. 57, № 38. P. 843—847.Herrlinger U., Kuker W., Uhl M., Blaicher H.P., Karnath H.O., Kanz L. et al. NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final report // Ann Neurol. 2005. Vol. 57, № 38. P. 843—847.Hormigo A., Abrey L., Heinemann M.H., DeAngelis L.M. Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment // Br J Haematol. 2004. Vol. 126. P. 202—208.Hormigo A., Abrey L., Heinemann M.H., DeAngelis L.M. Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment // Br J Haematol. 2004. Vol. 126. P. 202—208.Jack C.R. Jr, O’Neill B.P., Banks P.M., Reese D.F. et al. Primary central nervous system lymphoma: histologic types and CT appearance // Radiology. 1988. Vol. 167, № 23. P. 211—215.Jack C.R. Jr, O’Neill B.P., Banks P.M., Reese D.F. et al. Primary central nervous system lymphoma: histologic types and CT appearance // Radiology. 1988. Vol. 167, № 23. P. 211—215.Jahnke K.et al. Implications of the blood—brain barrier in primary central nervous system lymphoma // Neurosurg Focus. 2006. Vol. 21. № 5. E11.Jahnke K.et al. Implications of the blood—brain barrier in primary central nervous system lymphoma // Neurosurg Focus. 2006. Vol. 21. № 5. E11.Kadoch C., Treseler P., Rubenstein J.L. Molecular pathogenesis of primary central nervous system lymphoma // Neurosurg Focus. 2006. Vol 21. № 5. E1.Kadoch C., Treseler P., Rubenstein J.L. Molecular pathogenesis of primary central nervous system lymphoma // Neurosurg Focus. 2006. Vol 21. № 5. E1.Kawasaki K., Wakabayashi K., Koizumi T., Tanaka R., Takahashi H. Spinal cord involvement of primary central nervous system lymphomas: histopathological examination of 14 autopsy cases // Neuropathology. 2002. Vol. 22. P. 13—18.Kawasaki K., Wakabayashi K., Koizumi T., Tanaka R., Takahashi H. Spinal cord involvement of primary central nervous system lymphomas: histopathological examination of 14 autopsy cases // Neuropathology. 2002. Vol. 22. P. 13—18.Khan R.B., Weije S., Thaler H.T. et al. Is intrathecal methotrexate necessary in the treatment of primary CNS lymphoma? // J Neurooncol. 2002. Vol. 58. P. 175— 178.Khan R.B., Weije S., Thaler H.T. et al. Is intrathecal methotrexate necessary in the treatment of primary CNS lymphoma? // J Neurooncol. 2002. Vol. 58. P. 175— 178.Kumanishi T., Zhang S., Ichikawa T., Endo S., Washiyama K. Primary malignant lymphoma of the brain: demonstration of frequent p16 and p15 gene deletions // Jpn J Cancer Res. 1996. Vol. 87. P. 691—695.Kumanishi T., Zhang S., Ichikawa T., Endo S., Washiyama K. Primary malignant lymphoma of the brain: demonstration of frequent p16 and p15 gene deletions // Jpn J Cancer Res. 1996. Vol. 87. P. 691—695.Lantos P.L., VandenBerg S.R., Kleihues P. Tumours of the nervous system. Greenfield’s Neuropathology, vol 2, ed 6. New York, Oxford University Press, 1997Lantos P.L., VandenBerg S.R., Kleihues P. Tumours of the nervous system. Greenfield’s Neuropathology, vol 2, ed 6. New York, Oxford University Press, 1997Larocca L.M., Capello D. et al. The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells // Blood. 1998. Vol. 92. P. 1011—1019.Larocca L.M., Capello D. et al. The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells // Blood. 1998. Vol. 92. P. 1011—1019.Lutz J.M., Coleman M.P. Trends in primary cerebral lymphoma // Brit J Cancer. 1994. Vol. 716. Р. 70.Lutz J.M., Coleman M.P. Trends in primary cerebral lymphoma // Brit J Cancer. 1994. Vol. 716. Р. 70.Makino K., Nakamura H., Kudo M., Takeshima H., Kuratsu J. Complete response to temozolomide treatment in an elderly patient with recurrent primary central nervous system lymphoma — case report // Neurol Med Chir (Tokyo). 2007. Vol. 47. №5. Р. 229—232.Makino K., Nakamura H., Kudo M., Takeshima H., Kuratsu J. Complete response to temozolomide treatment in an elderly patient with recurrent primary central nervous system lymphoma — case report // Neurol Med Chir (Tokyo). 2007. Vol. 47. №5. Р. 229—232.McAllister L.D., Doolittle N.D., Guastadisegni P.E. et al. Cognitive outcomes and long-term follow-up after enhanced chemotherapy delivery for primary central nervous system lymphomas // Neurosurgery. 2000. Vol. 46. P. 51—61.McAllister L.D., Doolittle N.D., Guastadisegni P.E. et al. Cognitive outcomes and long-term follow-up after enhanced chemotherapy delivery for primary central nervous system lymphomas // Neurosurgery. 2000. Vol. 46. P. 51—61.McGowan J.P., Shah S. Long-term remission of AIDSrelated PCNSL associated with HAART // AIDS. 1998. P. 952—954.McGowan J.P., Shah S. Long-term remission of AIDSrelated PCNSL associated with HAART // AIDS. 1998. P. 952—954.Olson J.E., Janney C.A., Rao R.D., Cerhan J.R., Kurtin P.J., Schiff D. et al. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis // Cancer. 2002. Vol. 95. P. 1504—1510.Olson J.E., Janney C.A., Rao R.D., Cerhan J.R., Kurtin P.J., Schiff D. et al. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis // Cancer. 2002. Vol. 95. P. 1504—1510.O’Neill B.P., Illig J. Primary central nervous system lymphoma // Mayo Clin. Proc. 1989. Vol. 64. P. 1005—1020.O’Neill B.P., Illig J. Primary central nervous system lymphoma // Mayo Clin. Proc. 1989. Vol. 64. P. 1005—1020.O’Neill, B.P., Kelly, P.J., Earle, J.D., Scheithauer, B., and Banks. Computer-assisted stereotaxic biopsy for the diagnosis of primary central lymphoma // Neurology. 1987. Vol. 37. Р. 1160—1164.O’Neill, B.P., Kelly, P.J., Earle, J.D., Scheithauer, B., and Banks. Computer-assisted stereotaxic biopsy for the diagnosis of primary central lymphoma // Neurology. 1987. Vol. 37. Р. 1160—1164.Peterson K., Gordon K.B., Heinemann M.H., DeAngelis L.M. The clinical spectrum of ocular lymphoma // Cancer. 1993. Vol. 72. P. 843—849.Peterson K., Gordon K.B., Heinemann M.H., DeAngelis L.M. The clinical spectrum of ocular lymphoma // Cancer. 1993. Vol. 72. P. 843—849.Phan T.G., O’Neill B. P., Kurtin P. J. Posttransplant primary CNS lymphoma // Neuro-Oncology. 2000. Vol. 10. P. 229—238.Phan T.G., O’Neill B. P., Kurtin P. J. Posttransplant primary CNS lymphoma // Neuro-Oncology. 2000. Vol. 10. P. 229—238.Poortmans P.M., Kluin-Nelemans H.C., Haaxma-Reiche H., Van’t Veer M., Hansen M., Soubeyran P. et al. High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma. European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962 // J Clin Oncol. 2003. Vol. 21. P. 4483—4488.Poortmans P.M., Kluin-Nelemans H.C., Haaxma-Reiche H., Van’t Veer M., Hansen M., Soubeyran P. et al. High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma. European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962 // J Clin Oncol. 2003. Vol. 21. P. 4483—4488.Porcu P., Caligiuri M.A. Acquired immunodeficiency syndrome-related lymphomas: future directions // Seminars in Oncology. 2000. Vol. 27. № 4. P. 454—462.Porcu P., Caligiuri M.A. Acquired immunodeficiency syndrome-related lymphomas: future directions // Seminars in Oncology. 2000. Vol. 27. № 4. P. 454—462.Raez L., Cabral L., Cai J.P. et al. Treatment of AIDS-related primary central nervous system lymphoma with zidovudine, ganciclovir, and interleukin 2 // AIDS Res Hum Retroviruses. 1999. Vol. 15. P. 713—719.Raez L., Cabral L., Cai J.P. et al. Treatment of AIDS-related primary central nervous system lymphoma with zidovudine, ganciclovir, and interleukin 2 // AIDS Res Hum Retroviruses. 1999. Vol. 15. P. 713—719.Reni M. Salvage chemotherapy with temozolomide in primary CNS lymphomas: preliminary results of a phase II trial // Eur J Cancer. 2004. Vol. 40. № 11. P. 1682—1688.Reni M. Salvage chemotherapy with temozolomide in primary CNS lymphomas: preliminary results of a phase II trial // Eur J Cancer. 2004. Vol. 40. № 11. P. 1682—1688.Roman-Goldstein S., Goldman D., Howieson.J, et al. MRI of primary CNS lymphoma in immunologically normal patients // Am J Neuroradiol. 1992. Vol. 13. P. 1207—1213.Roman-Goldstein S., Goldman D., Howieson.J, et al. MRI of primary CNS lymphoma in immunologically normal patients // Am J Neuroradiol. 1992. Vol. 13. P. 1207—1213.Russell and Rubinstein’s. Pathology of Tumors of the Nervous System, 6th edn. Arnold, a member of Hodder Headline Group: London; 1998. P. 198—210.Russell and Rubinstein’s. Pathology of Tumors of the Nervous System, 6th edn. Arnold, a member of Hodder Headline Group: London; 1998. P. 198—210.Sandlund J.T., Murphy S.B., Santana V.M. et al. CNS involvement in children with newly diagnosed non-Hodgkin’s lymphoma // J Clin Oncol. 2000. Vol. 18. P. 3018—3024.Sandlund J.T., Murphy S.B., Santana V.M. et al. CNS involvement in children with newly diagnosed non-Hodgkin’s lymphoma // J Clin Oncol. 2000. Vol. 18. P. 3018—3024.Schultz C., Scott C., Sherman W. et al. Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: Initial report of Radiation Therapy Oncology Group protocol 88-06 // J Clin Oncol. 1996. Vol. 14. P. 556—564.Schultz C., Scott C., Sherman W. et al. Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: Initial report of Radiation Therapy Oncology Group protocol 88-06 // J Clin Oncol. 1996. Vol. 14. P. 556—564.Thiessen B., DeAngelis L.M. Hydrocephalus in radiation leukoencephalopathy: results of ventriculoperitoneal shunting // Arch Neurol. 1998. Vol. 55. P. 705—710.Thiessen B., DeAngelis L.M. Hydrocephalus in radiation leukoencephalopathy: results of ventriculoperitoneal shunting // Arch Neurol. 1998. Vol. 55. P. 705—710.Todaro L., Christiansen S., Varela M., Campodуnico P., Pallotta M.G., Lastiri J., Sacerdote de Lustig E., Bal de Kier Joffй E., Puricelli L. Alteration of serum and tumoral neural cell adhesion molecule (NCAM) isoforms in patients with brain tumors // J Neurooncol. 2007. Vol. 83. № 2. P. 135—44.Todaro L., Christiansen S., Varela M., Campodуnico P., Pallotta M.G., Lastiri J., Sacerdote de Lustig E., Bal de Kier Joffй E., Puricelli L. Alteration of serum and tumoral neural cell adhesion molecule (NCAM) isoforms in patients with brain tumors // J Neurooncol. 2007. Vol. 83. № 2. P. 135—44.Welch K, Finkbeiner W, Alpers CE, et al. Autopsy findings in the acquired immune deficiency syndrome // JAMA. 1984. Vol. 252. P. 1152—1159.Welch K, Finkbeiner W, Alpers CE, et al. Autopsy findings in the acquired immune deficiency syndrome // JAMA. 1984. Vol. 252. P. 1152—1159.Zimmer C., Marzheuser S., Patt S., Rolfs A., Gottschalk J., Weigel K. et al. Stereotactic brain biopsy in AIDS // J Neurol. 1992. Vol. 239. P. 394—400.Zimmer C., Marzheuser S., Patt S., Rolfs A., Gottschalk J., Weigel K. et al. Stereotactic brain biopsy in AIDS // J Neurol. 1992. Vol. 239. P. 394—400.

The authors declare that there are no conflicts of interest present.